How might novel technologies such as optogenetics lead to better treatments in epilepsy?

Esther Krook-Magnuson, Marco Ledri, Ivan Soltesz, Merab Kokaia

Research output: Chapter in Book/Report/Conference proceedingChapter

15 Scopus citations


Recent technological advances open exciting avenues for improving the understanding of mechanisms in a broad range of epilepsies. This chapter focuses on the development of optogenetics and on-demand technologies for the study of epilepsy and the control of seizures. Optogenetics is a technique which, through cell-type selective expression of light-sensitive proteins called opsins, allows temporally precise control via light delivery of specific populations of neurons. Therefore, it is now possible not only to record interictal and ictal neuronal activity, but also to test causality and identify potential new therapeutic approaches. We first discuss the benefits and caveats to using optogenetic approaches and recent advances in optogenetics related tools. We then turn to the use of optogenetics, including on-demand optogenetics in the study of epilepsies, which highlights the powerful potential of optogenetics for epilepsy research.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
Subtitle of host publicationA View from the Bench
PublisherSpringer New York LLC
Number of pages18
ISBN (Print)9789401789134
StatePublished - 2014

Publication series

NameAdvances in Experimental Medicine and Biology
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019


  • AAV
  • Arch
  • Channelrhodopsin
  • Halorhodopsin
  • On-demand
  • Optrode
  • Responsive
  • Seizure

PubMed: MeSH publication types

  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review


Dive into the research topics of 'How might novel technologies such as optogenetics lead to better treatments in epilepsy?'. Together they form a unique fingerprint.

Cite this